This website uses cookies to enhance the user experience.
NORDISK BIOGASS AS

NORDISK BIOGASS AS985 309 434

Research
Limited company
Sandavegen 15 3802 BØ I TELEMARK, Norge

NORDISK BIOGASS AS

Nordisk Biogass

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Links

Organization

CEO
Chairman of the board
Years since formation
22 years
since Jan 31, 2003
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
23,177,097
1 share class
Total number of shareholders
3
2 companies, 1 person
Belongs to group of

Financials

Total operating income 2024
15,865,848
NOK
Annual total result 2024
-18,991,361
NOK
Total equity 2024
-14,772,471
NOK
Last update: Jul 22, 2025

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman
60.16 %
indirectly
Board Member-
Board Member
17.45 %
indirectly

Others

NameRoleShares
H
HAUGERUD REGNSKAPSKONTOR AS
Accountant-
P
PRICEWATERHOUSECOOPERS AS
Auditor-

Top 10 individual shareholders

NameRoleShares
Chairman
60.16 %
indirectly
Board Member
17.45 %
indirectly
-
4.38 %
indirectly
-
2 %
indirectly
-
2 %
indirectly
-
2 %
indirectly
-
1.5 %
indirectly
-
1.5 %
indirectly
-
1.5 %
indirectly
-
1.5 %
indirectly
Last update: Apr 10, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
B
BRI AGRI AS
Ordinary shares
13,942,903
60.16 %
Ordinary shares
9,232,344
39.83 %
Ordinary shares
1,850
< 0.01 %
Last update: Jun 2, 2025

Group structure

  • Total operating income 2024: NOK 4,829,428
    Operating profit 2024: NOK -9,494,835
    Employees: 0

Financials

in NOK

Summary

Year2024202320222021
Total operating income
15,865,848
23,393,062
5,617,318
1,605,000
Annual Total Result
-18,991,361
-15,429,556
-3,528,931
-16,909
Total assets
8,650,255
13,897,120
10,578,626
2,506,562
Total liabilities
23,422,725
32,580,745
13,832,695
2,231,699
Total equity
-14,772,471
-18,683,625
-3,254,069
274,863

P&L

Year2024202320222021
Total operating income
15,865,848
23,393,062
5,617,318
1,605,000
Total operating costs
33,984,864
38,357,186
9,125,039
1,612,230
Operating result
-18,119,016
-14,964,124
-3,507,721
-7,230
Financial income/costs
-872,345
-465,432
-21,210
-9,679
Profit before tax
-18,991,361
-15,429,556
-3,528,931
-16,909
Total tax & extraordinary income/cost
0
0
0
0
Annual Total Result
-18,991,361
-15,429,556
-3,528,931
-16,909

Balance overview

Year2024202320222021
Total fixed assets
1,733,615
2,178,462
2,698,422
0
Total current assets
6,916,640
11,718,658
7,880,204
2,506,562
Total assets
8,650,255
13,897,120
10,578,626
2,506,562
Short term debt
12,889,214
25,741,473
11,731,639
196,432
Long term debt
10,533,511
6,839,272
2,101,056
2,035,267
Total liabilities
23,422,725
32,580,745
13,832,695
2,231,699
Contributed capital
23,997,876
510,615
510,615
510,615
Retained earnings
-38,770,347
-19,194,240
-3,764,684
-235,752
Total equity
-14,772,471
-18,683,625
-3,254,069
274,863
Total equity and liabilities
8,650,255
13,897,120
10,578,626
2,506,562

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology